Literature DB >> 28369528

Secondary use of data from hospital electronic prescribing and pharmacy systems to support the quality and safety of antimicrobial use: a systematic review.

Christianne Micallef1,2, Navila T Chaudhry3,4, Alison H Holmes1,5, Susan Hopkins1,6, Jonathan Benn4, Bryony Dean Franklin1,3,4,7.   

Abstract

Background: Electronic prescribing (EP) and electronic hospital pharmacy (EHP) systems are increasingly common. A potential benefit is the extensive data in these systems that could be used to support antimicrobial stewardship, but there is little information on how such data are currently used to support the quality and safety of antimicrobial use.
Objectives: To summarize the literature on secondary use of data (SuD) from EP and EHP systems to support quality and safety of antimicrobial use, to describe any barriers to secondary use and to make recommendations for future work in this field.
Methods: We conducted a systematic search within four databases; we included original research studies that were (1) based on SuD from hospital EP or EHP systems and (2) reported outcomes relating to quality and/or safety of antimicrobial use and/or qualitative findings relating to SuD in this context.
Results: Ninety-four full-text articles were obtained; 14 met our inclusion criteria. Only two described interventions based on SuD; seven described SuD to evaluate other antimicrobial stewardship interventions and five described descriptive or exploratory studies of potential applications of SuD. Types of data used were quantitative antibiotic usage data ( n  =   9 studies), dose administration data ( n  =   4) and user log data from an electronic dashboard ( n  = 1). Barriers included data access, data accuracy and completeness, and complexity when using data from multiple systems or hospital sites. Conclusions: The literature suggests that SuD from EP and EHP systems is potentially useful to support or evaluate antimicrobial stewardship activities; greater system functionality would help to realize these benefits.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Mesh:

Substances:

Year:  2017        PMID: 28369528     DOI: 10.1093/jac/dkx082

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  4 in total

1.  Cross-border comparison of antimicrobial resistance (AMR) and AMR prevention measures: the healthcare workers' perspective.

Authors:  J Keizer; L M A Braakman-Jansen; S Kampmeier; R Köck; N Al Naiemi; R Te Riet-Warning; N Beerlage-De Jong; K Becker; J E W C Van Gemert-Pijnen
Journal:  Antimicrob Resist Infect Control       Date:  2019-07-22       Impact factor: 4.887

2.  Finding the match between healthcare worker and expert for optimal audit and feedback on antimicrobial resistance prevention measures.

Authors:  J Keizer; N Beerlage-De Jong; N Al Naiemi; J E W C van Gemert-Pijnen
Journal:  Antimicrob Resist Infect Control       Date:  2020-08-05       Impact factor: 4.887

Review 3.  The Secondary Use of Data to Support Medication Safety in the Hospital Setting: A Systematic Review and Narrative Synthesis.

Authors:  Navila Talib Chaudhry; Bryony Dean Franklin; Salmaan Mohammed; Jonathan Benn
Journal:  Pharmacy (Basel)       Date:  2021-12-13

4.  Feasibility study of hospital antimicrobial stewardship analytics using electronic health records.

Authors:  P F Dutey-Magni; M J Gill; D McNulty; G Sohal; A Hayward; L Shallcross; Niall Anderson; Elise Crayton; Gillian Forbes; Arnoupe Jhass; Emma Richardson; Michelle Richardson; Patrick Rockenschaub; Catherine Smith; Elizabeth Sutton; Rosanna Traina; Lou Atkins; Anne Conolly; Spiros Denaxas; Ellen Fragaszy; Rob Horne; Patty Kostkova; Fabiana Lorencatto; Susan Michie; Jennifer Mindell; John Robson; Claire Royston; Carolyn Tarrant; James Thomas; Jonathan West; Haydn Williams; Nadia Elsay; Chris Fuller
Journal:  JAC Antimicrob Resist       Date:  2021-03-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.